Haemonetics

Yahoo Finance • 3 hours ago

Is Haemonetics Corporation (HAE) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?

We recently published a list of 11 Best Russell 2000 Stocks to Buy According to Wall Street Analysts. In this article, we are going to take a look at where Haemonetics Corporation (NYSE:HAE) stands against other best Russell 2000 stocks to... Full story

Yahoo Finance • 2 days ago

Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest

Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices &... Full story

Yahoo Finance • 9 days ago

3 Stocks That May Be Trading Below Their Estimated Value In April 2025

As the United States stock market navigates a period of volatility amid President Trump's anticipated announcement on new tariffs, major indices like the Dow Jones and S&P 500 have shown resilience with recent gains despite earlier decline... Full story

Yahoo Finance • 2 months ago

3 US Stocks Estimated To Be Trading Below Their Intrinsic Values

In a week marked by significant declines across major U.S. indices, with the Dow experiencing its worst performance since October and the Nasdaq facing its largest drop in three months, investors are keenly searching for opportunities amid... Full story

Yahoo Finance • 2 months ago

3 US Stocks That May Be Trading Below Their Estimated Value

As the U.S. stock market navigates a mixed landscape, with major indices showing varied movements and recent selloffs impacting investor sentiment, opportunities may arise for those looking to identify stocks that are trading below their e... Full story

Yahoo Finance • 2 months ago

US Stocks Trading Below Estimated Value In February 2025

As of February 2025, the U.S. stock market has experienced a mixed performance with recent declines following record highs for major indices like the S&P 500. This fluctuation presents an opportunity to explore stocks that may be trading b... Full story

Yahoo Finance • 2 months ago

Haemonetics Third Quarter 2025 Earnings: Misses Expectations

Haemonetics (NYSE:HAE) Third Quarter 2025 Results Key Financial Results Revenue: US$348.5m (up 3.7% from 3Q 2024). Net income: US$37.5m (up 20% from 3Q 2024). Profit margin: 11% (up from 9.3% in 3Q 2024). The increase in margin was drive... Full story

Yahoo Finance • 2 months ago

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Financial release accessible online BOSTON, Feb. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2025, which ended December 28, 2024, are available on its Inve... Full story

Yahoo Finance • 7 months ago

Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025

We recently published a list of 10 Worst Affordable Stocks To Buy Right Now. In this article, we are going to take a look at where Haemonetics Corporation (NYSE:HAE) stands against other worst affordable stocks to buy right now. How is th... Full story

Yahoo Finance • last year

Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference

BOSTON, Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 45th Annual Institutional Investors Conference... Full story

Yahoo Finance • last year

Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day

BOSTON, Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at Citi's 2024 Unplugged Medtech and Life Sciences Access Day on Th... Full story

Yahoo Finance • last year

25 Most Valuable Medical Device Companies in the US

In this article, we will be taking a look at the 25 most valuable medical device companies in the US. If you are not interested in learning about the emerging trend in medical device industry, head straight to the 5 Most Valuable Medical D... Full story

Yahoo Finance • last year

Haemonetics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Haemonetics (NYSE:HAE) Third Quarter 2024 Results Key Financial Results Revenue: US$336.3m (up 10% from 3Q 2023). Net income: US$31.2m (down 5.2% from 3Q 2023). Profit margin: 9.3% (down from 11% in 3Q 2023). The decrease in margin was d... Full story

Yahoo Finance • last year

Q3 2024 Haemonetics Corp Earnings Call

Participants Olga Guyette; Director, IR; Haemonetics Corporation Chris Simon; President and CEO; Haemonetics Corporation James D'Arecca; EVP, CFO; Haemonetics Corporation Presentation Operator Good day, and thank you for standing by.... Full story

Yahoo Finance • last year

Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Financial release accessible online BOSTON, Feb. 8, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2024, which ended December 30, 2023, are available on its Inve... Full story

Yahoo Finance • last year

The three-year underlying earnings growth at Haemonetics (NYSE:HAE) is promising, but the shareholders are still in the red over that time

Many investors define successful investing as beating the market average over the long term. But the risk of stock picking is that you will likely buy under-performing companies. We regret to report that long term Haemonetics Corporation (... Full story

Yahoo Finance • last year

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024

BOSTON, Jan. 11, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2024 financial results at 6:00 am ET on Thursday, February 8, 2024. The Company will hold a c... Full story

Yahoo Finance • 2 years ago

These Two Stocks Make New Highs, Hold In Buy Zones

New highs are rare for stocks when major indexes hit resistance. Yet HAE and LECO are climbing to 52-week highs and are in buy zones. Continue reading... Full story

Yahoo Finance • 2 years ago

Haemonetics to Present at 41st Annual J.P. Morgan Healthcare Conference

BOSTON, Dec. 19, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 10, 2023 at 2:1... Full story

Yahoo Finance • 2 years ago

Is Haemonetics Corporation's (NYSE:HAE) 12% ROE Better Than Average?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). We'll use ROE to examine Haemonetics Corporation (NYSE:H... Full story